Epstein—Barr Virus Binding to Virus-carrying Cell Lines is Enhanced in the Presence of C3 and C3d

References

1. Abu Sinna G., Lundgren E., Nilsson K., Roos G. 1980; Isozymes of amino acid naphthylamidase in human haemapoietic cell lines. British Journal of Haematology 44:25–32
   [Google Scholar]
2. Bokisch V. A., Müller-Eberhard H. J., Cochrane C. G. 1969; Isolation of a fragment (C3a) of the third component of human complement containing anaphylatoxin and chemotactic activity and description of an anaphylatoxin inactivator of human serum. Journal of Experimental Medicine 129:1109–1130
   [Google Scholar]
3. Einhom L., Steinitz M., Yefenof E., Ernberg I., Bakacs T., Klein G. 1978; Epstein-Barr virus (EBV) receptors, complement receptors, and EBV infectibility of different lymphocyte fractions of human peripheral blood. II. Epstein-Barr virus studies. Cellular Immunology 35:43–58
   [Google Scholar]
4. Epstein M. A., Achong B. (editors) 1979; The Epstein-Barr Virus. Berlin, Heidelberg & New York: Springer-Verlag;
   [Google Scholar]
5. Epstein M. A., Achong B., Barr Y., Zajac B., Henle G., Henle W. 1966; Morphological and virological investigation of cultured Burkitt tumor lymphoblasts (strain Raji). Journal of the National Cancer Institute 37:547–559
   [Google Scholar]
6. Fresen K., Zur Hausen H. 1976; Establishment of EBNA-expressing cell lines by infection of EBV-genome negative human lymphoma cells with different EBV strains. International Journal of Cancer 17:161–166
   [Google Scholar]
7. Gerdes J., Stein H. 1981; Human membrane-bound C3 receptors. II. Physiochemical properties of the C3b and C3d receptors isolated from tonsil cells by immunoprecipitation. Scandinavian Journal of Immunology 13:77–86
   [Google Scholar]
8. Glaser R., Lenoir G., Ferrone S., Pellegrino M., De Thé G. 1977; Cell surface markers on epithelial-Burkitt hybrid cells superinfected with Epstein-Barr virus. Cancer Research 37:2291–2296
   [Google Scholar]
9. Jondal M., Klein G., Oldstone M. B. A., Bokish E., Yefenof V. E. 1976; Surface markers on human B and T lymphocytes. VIII. Association between complement and Epstein-Barr virus receptors on human lymphoid cells. Scandinavian Journal of Immunology 5:401–410
   [Google Scholar]
10. Jønsson V., Wells A., Klein G. 1982; Receptors for the complement C3d component and the Epstein-Barr virus are quantitatively co-expressed on a series of B-cell lines and their derived somatic cell hybrids. Cellular Immunology 72:263–276
    [Google Scholar]
11. Kakiuchi T., Mariuchi H. 1981; Responses of B cells with or without C3 receptors to polyclonal B-cell activators. Journal of Immunology 127:954–958
    [Google Scholar]
12. Klein G., Dombos L. 1973; Relationship between the sensitivity of EBV-carrying lymphoblastoid lines to superinfection and the inducibility of the resident viral genome. International Journal of Cancer 11:327–337
    [Google Scholar]
13. Klein G., Yefenof E., Falk A., Westman K. 1978; Relationship between Epstein-Barr virus (EBV)-production and the loss of the EBV receptor/complement receptor complex in a series of sublines derived from the same original Burkitt’s lymphoma. International Journal of Cancer 21:552–560
    [Google Scholar]
14. Klein G., Manneborg A., Steinitz M. 1979; Differences in EBV receptor concentration between in vitro EBV-converted lymphoma sublines reflect biological differences between the converting viral substrains. International Journal of Cancer 23:197–200
    [Google Scholar]
15. Koide N., Wells A., Volsky D. J., Shapiro I. M., Klein G. 1981; The detection of Epstein-Barr virus receptors utilizing radiolabelled virus. Journal of General Virology 54:191–195
    [Google Scholar]
16. Lundwall A., Hellman U., Eggertsen G., Sjöquist J. 1982; Isolation of tryptic fragments of human C4 expressing Chido and Rodgers antigens. Molecular Immunology 12:1655–1665
    [Google Scholar]
17. Mariuchi H., Kakiuchi T. 1982; Antibody responses to various T-independent antigens of B cells with or without C3 receptors and adherent cell requirement for these responses. Journal of Immunology 128:161–167
    [Google Scholar]
18. Menezes I., Jondal M., Leibold W., Dorval G. 1976; Epstein-Barr virus interactions with human lymphocyte subpopulations: virus adsorption, kinetics of expression of Epstein-Barr virus-associated nuclear antigen, and lymphocyte transformation. Infection and Immunity 13:303–310
    [Google Scholar]
19. Menezes J., Sergnewron J., Patel P., Bourkas A., Lenoir G. 1977; Presence of Epstein-Barr virus receptors, but absence of virus penetration, in cells of an Epstein-Barr virus genome-negative human lymphoblastoid T line (Molt-4). Journal of Virology 22:816–821
    [Google Scholar]
20. Nilsson C., Sundström K. 1974; Establishment and characteristics of two unique cell lines from patients with lymphosarcoma. International Journal of Cancer 13:808–823
    [Google Scholar]
21. Praz F., Lesavre P. 1983; Alternative pathway of complement activation by human lymphoblastoid B and T cell lines. Journal of Immunology 131:1396–1399
    [Google Scholar]
22. Schulz T., Dierich M. P., Yefenof E., Klein G. 1980; C3-activating proteases on human lymphoblastoid cells superinfected with Epstein-Barr virus. Cellular Immunology 51:168–172
    [Google Scholar]
23. Stein H., Gerdes J., Tolkdorf G., Klatt U. 1981; Human membrane-bound C3 receptors. I. Serological and immunohistological demonstration of C3 receptors. Scandinavian Journal of Immunology 13:67–76
    [Google Scholar]
24. Taylor J., Crawford T., Hugli I. 1977; Limited degradation of the third component (C3) of human complement by human leukocyte elastase (HLE). Partial characterization of C3 fragments. Biochemistry 16:3390–3396
    [Google Scholar]
25. Wells A., Koide N., Klein G. 1981a; Difference in viral binding between two Epstein-Barr virus substrains to a spectrum of receptor-positive target cells. International Journal of Cancer 27:303–309
    [Google Scholar]
26. Wells A., Steen H. B., Saeland S., Godal G., Klein T. 1981b; A microassay for quantitatively detecting the Epstein-Barr virus receptor on single cells utilizing flow cytometry. Journal of Virological Methods 3:127–136
    [Google Scholar]
27. Wells A., Godal T., Kvaloy S., Steen G., Klein H. B. 1982a; Quantitative comparison of Epstein-Barr virus receptor expression on sIgM and sIgG cell lines and B-cell lymphoma biopsies. Differentiation 22:113–119
    [Google Scholar]
28. Wells A., Koide G., Klein N. 1982b; Two large virion envelope glycoproteins mediate Epstein-Barr virus binding to receptor-positive cells. Journal of Virology 41:286–297
    [Google Scholar]
29. Wells A., Koide N., Stein H., Gerdes J., Klein G. 1983; The Epstein-Barr virus receptor is distinct from the C3 receptor. Journal of General Virology 64:449–453
    [Google Scholar]
30. Yefenof E., Klein G. 1977; Membrane receptor stripping confirms the association between EBV receptors and complement receptors on the surface of human B lymphoma lines. International Journal of Cancer 20:347–352
    [Google Scholar]
31. Yefenof E., Klein G., Jondal M. B. A., Oldstone M. 1976; Surface markers on human B and T lymphocytes. IX. Two-color immunofluorescence studies on the association between EBV receptors and complement receptors on the surface of lymphoid cell lines. International Journal of Cancer 17:693–700
    [Google Scholar]
32. Yefenof E., Klein K., Kvarnung G. 1977; Relationship between complement activation, complement binding, and EBV absorption by human hemapoietic cell lines. Cellular Immunology 31:225–233
    [Google Scholar]